| ASSET | YEAR | % RETURN |
|---|---|---|
Xpeng (XPEV) | 2025 | 74.76% |
Hims Hers Health (HIMS) | 2025 | 64.46% |
Intracellular Th (ITCI) | 2025 | 55.94% |
Alibaba (BABA) | 2025 | 53.87% |
CVS Health (CVS) | 2025 | 44.15% |
Banco Santander SA ADR (SAN) | 2025 | 42.51% |
Lloyds Banking Group PLC ADR (LYG) | 2025 | 41.48% |
BeiGene (ONC) | 2025 | 40.99% |
Banco Bilbao Viscaya Argentaria SA ADR (BBVA) | 2025 | 39.37% |
Gold Fields Ltd ADR (GFI) | 2025 | 37.93% |
Futu (FUTU) | 2025 | 37.49% |
Dutch Bros (BROS) | 2025 | 37.05% |
Okta (OKTA) | 2025 | 35.39% |
Royalty Pharma (RPRX) | 2025 | 31.28% |
ArcelorMittal SA ADR (MT) | 2025 | 30.88% |
Spotify Technology (SPOT) | 2025 | 29.64% |
Elbit Systems (ESLT) | 2025 | 29.49% |
AngloGold Ashanti (AU) | 2025 | 28.08% |
Philip Morris International (PM) | 2025 | 26.87% |
Super Micro Computer (SMCI) | 2025 | 26.38% |
Doximity (DOCS) | 2025 | 25.84% |
Sea (SE) | 2025 | 25.78% |
Nutanix (NTNX) | 2025 | 25.13% |
Gilead Sciences (GILD) | 2025 | 23.88% |
Tapestry (TPR) | 2025 | 23.85% |
Large-cap stocks are treated as having a market cap of $10B+.
